Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? (Q37546194)

20 August 2017

1 reference

title

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? (English)

1 reference

20 August 2017

0 references

0 references

0 references

Susanne Oesch

1

1 reference

PubMed ID

19589225

20 August 2017

Jürg Gertsch

series ordinal

2

1 reference

20 August 2017

1 July 2009

1 reference

Journal of Pharmacy and Pharmacology

20 August 2017

1 reference

20 August 2017

61

1 reference

20 August 2017

7

1 reference

20 August 2017

839-853

1 reference

Cannabinoid receptors as therapeutic targets.

20 August 2017

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Novel cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The orphan receptor GPR55 is a novel cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The therapeutic potential of novel cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Discovery and isolation of anandamide and other endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Anandamide and vanilloid TRPV1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Anandamide effects on 5-HT(3) receptors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The enigmatic pharmacology of GPR55

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Endocannabinoids and the regulation of bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Targeting the endocannabinoid system: to enhance or reduce?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid-based drugs as anti-inflammatory therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Role of cannabinoids in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

CNS immune surveillance and neuroinflammation: endocannabinoids keep control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Endocannabinoid overactivity and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Attenuation of allergic contact dermatitis through the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The peripheral cannabinoid receptor knockout mice: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor type 2 gene is associated with human osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Peripheral cannabinoid receptor, CB2, regulates bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptors and the regulation of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The cannabinoid CB(2) receptor: a good friend in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The role of the endocannabinoid system in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids and cancer: pros and cons of an antitumour strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The endocannabinoid system in cancer-potential therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids for cancer treatment: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Antineoplastic Activity of Cannabinoids2

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

G-protein-coupled receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids and ceramide: two lipids acting hand-by-hand

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids: between neuroprotection and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

PKB and the mitochondria: AKTing on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptors as novel targets for the treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The complexity of mitogen-activated protein kinases (MAPKs) made simple

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Beta-caryophyllene is a dietary cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Tumor microenvironment and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids reduce granuloma-associated angiogenesis in rats by controlling transcription and expression of mast cell protease-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

CB2 receptor-mediated migration of immune cells: it can go either way

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

CB2 cannabinoid receptors promote mouse neural stem cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta9-tetrahydrocannabinol increases C6 glioma cell death produced by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Possible endocannabinoid control of colorectal cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

GPR55: a new member of the cannabinoid receptor clan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Biochemistry and pharmacology of endovanilloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

PPAR-gamma: a nuclear receptor with affinity for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoid receptor as a novel target for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids in the management of difficult to treat pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

TNF and cancer: the two sides of the coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

TNF: a master switch for inflammation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Loss of cannabinoid receptor 1 accelerates intestinal tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Medicinal plants and cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabinoids as potential new therapy for the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Marijuana use and cancer incidence (California, United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Cannabis use and risk of lung cancer: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Doubts about the role of cannabis in causing lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Association of marijuana use and the incidence of testicular germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

Identification, Characterization, and Function of a Novel Oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.07.0002

21 January 2018

Identifiers

DOI

10.1211/JPP.61.07.0002

1 reference

20 August 2017

1 reference

PubMed ID

19589225